Basic and diluted earnings (loss) per share is calculated based on the weighted-average number of shares outstanding in each period and dilutive stock options, unvested shares and warrants, to the extent such securities exist and have a dilutive effect on earnings (loss) per share. A reconciliation of the numerator and denominator of basic and diluted earnings (loss) per share follows (dollars in millions, except per share amounts; shares in thousands):


	Three Months Ended March 31,
	2026		2025

Numerator:
Net income (loss) attributable to Surgery Partners, Inc.	$	(35.9)	$	(37.7)



Denominator:
Weighted average common shares outstanding:
Basic	128,367		126,602
Diluted (1)	128,367		126,602

Net loss per share attributable to common stockholders:
Basic	$	(0.28)	$	(0.30)
Diluted (1)	$	(0.28)	$	(0.30)

Dilutive securities outstanding not included in the computation of diluted loss per share as their effect is antidilutive:
Stock options	144		957
Restricted shares	115		138

(1)The impact of potentially dilutive securities for all periods was not considered because the effect would be anti-dilutive.